Armstrong AW, Park SH, Patel V, Hogan M, Wang W-J, Davidson D, Chirikov V. Matching-adjusted indirect comparison (MAIC) of deucravacitinib versus adalimumab for the treatment of patients with moderate to severe plaque psoriasis over 2 years. J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 4];7(2):s112. Available from: https://jofskin.org/33014/index.php/skin/article/view/1995